0001209191-18-003963.txt : 20180117
0001209191-18-003963.hdr.sgml : 20180117
20180117164023
ACCESSION NUMBER: 0001209191-18-003963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180117
DATE AS OF CHANGE: 20180117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18531862
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2018-01-16
4
M
0
2125
96.87
D
43013
D
Common Stock
2018-01-16
4
S
0
825
155.80
D
42188
D
Common Stock
2018-01-16
4
S
0
400
157.02
D
41788
D
Common Stock
2018-01-16
4
S
0
400
158.11
D
41388
D
Common Stock
2018-01-16
4
S
0
500
159.29
D
40888
D
Common Stock
5306
I
401(k)
Stock Option (Right to Buy)
96.87
2018-01-16
4
M
0
2125
0.00
D
2024-07-14
Common Stock
2125
4250
D
Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $155.80 (range $155.32 to $156.26).
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $157.02 (range $156.62 to $157.50).
Open market sales reported on this line occurred at a weighted average price of $158.11 (range $157.77 to $158.67).
Open market sales reported on this line occurred at a weighted average price of $159.29 (range $158.96 to $159.65).
The option vests in 16 quarterly installments from 7/15/2014.
/s/ Omar White, Attorney-in-Fact
2018-01-17